Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Johannes Gutenberg University of Mainz, Germany.
Centro de Apoio Tecnológico Agro Alimentar (CATAA), Zona Industrial de Castelo Branco, Portugal.
FEBS J. 2020 Feb;287(4):645-658. doi: 10.1111/febs.15055. Epub 2019 Sep 23.
Protease-activated receptors (PARs) are a unique class of G-protein-coupled transmembrane receptors, which revolutionized the perception of proteases from degradative enzymes to context-specific signaling factors. Although PARs are traditionally known to affect several vascular responses, recent investigations have started to pinpoint the functional role of PAR signaling in the gastrointestinal (GI) tract. This organ is exposed to the highest number of proteases, either from the gut lumen or from the mucosa. Luminal proteases include the host's digestive enzymes and the proteases released by the commensal microbiota, while mucosal proteases entail extravascular clotting factors and the enzymes released from resident and infiltrating immune cells. Active proteases and, in case of a disrupted gut barrier, even entire microorganisms are capable to translocate the intestinal epithelium, particularly under inflammatory conditions. Especially PAR-1 and PAR-2, expressed throughout the GI tract, impact gut permeability regulation, a major factor affecting intestinal physiology and metabolic inflammation. In addition, PARs are critically involved in the onset of inflammatory bowel diseases, irritable bowel syndrome, and tumor progression. Due to the number of proteases involved and the multiple cell types affected, selective regulation of intestinal PARs represents an interesting therapeutic strategy. The analysis of tissue/cell-specific knockout animal models will be of crucial importance to unravel the intrinsic complexity of this signaling network. Here, we provide an overview on the implication of PARs in intestinal permeability regulation under physiologic and disease conditions.
蛋白酶激活受体(PARs)是一类独特的 G 蛋白偶联跨膜受体,它们彻底改变了人们对蛋白酶的认识,使其从降解酶转变为具有特定作用的信号因子。尽管 PARs 传统上被认为会影响多种血管反应,但最近的研究开始确定 PAR 信号在胃肠道(GI)中的功能作用。该器官暴露于数量最多的蛋白酶,这些蛋白酶来自肠腔或黏膜。肠腔蛋白酶包括宿主的消化酶和共生微生物群释放的蛋白酶,而黏膜蛋白酶涉及血管外凝血因子以及驻留和浸润免疫细胞释放的酶。活性蛋白酶,甚至在肠道屏障被破坏的情况下,整个微生物都能够穿过肠上皮细胞,尤其是在炎症条件下。特别是在整个胃肠道表达的 PAR-1 和 PAR-2,影响肠道通透性调节,这是影响肠道生理学和代谢炎症的主要因素。此外,PARs 还与炎症性肠病、肠易激综合征和肿瘤进展密切相关。由于涉及的蛋白酶数量众多,以及受影响的多种细胞类型,选择性调节肠道 PARs 是一种很有前途的治疗策略。分析组织/细胞特异性基因敲除动物模型对于揭示该信号网络的内在复杂性至关重要。在这里,我们概述了 PARs 在生理和疾病条件下对肠道通透性调节的影响。